Eli Lilly Sues Glenmark Over Cancer Drug ANDA
Eli Lilly & Co. sued Glenmark Generics Inc. USA on Thursday in Indiana federal court, alleging the company's proposed generic version of its blockbuster cancer treatment drug Alimta infringes one of...To view the full article, register now.
Already a subscriber? Click here to view full article